首页> 外文期刊>Macromolecular bioscience >Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
【24h】

Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles

机译:苯硼酸官能化聚(D,L-丙交酯)-b-右旋糖酐纳米颗粒的粘膜粘附药物递送系统的开发

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mucoadhesive NP drug carriers have attracted substantial interest as a potential treatment for anterior eye diseases. NPs composed of PLA-Dex surface functionalized with a mucoadhesive ligand, PBA, were developed as drug carriers with particle sizes ranging from 25 to 28 nm. Using CycA as a model drug, we showed that NPs encapsulated up to 13.7 wt% CycA and exhibited sustained release for up to 5 d in vitro at a clinically relevant dose. We fine-tuned the PBA density on the NP surface to maximize the mucin-NP interaction without compromising the particle stability in vitro. This block copolymer conjugate may be useful to improve the bioavailability of topical formulations.
机译:粘膜粘附性NP药物载体作为前眼疾病的潜在治疗方法已引起广泛关注。由PLA-Dex表面被粘膜粘附配体PBA官能化的NP被开发为粒径为25至28 nm的药物载体。使用CycA作为模型药物,我们显示NPs封装的CycA含量高达13.7 wt%,并在临床上以相关剂量在体外显示长达5 d的持续释放。我们微调了NP表面上的PBA密度,以最大程度提高粘蛋白与NP的相互作用,而不会影响体外的颗粒稳定性。该嵌段共聚物共轭物可用于改善局部制剂的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号